%0 Journal Article
%T Cataract Development Among Pediatric Patients With Uveitis.
%A Hsu AY
%A Kuo HT
%A Lin CJ
%A Hsia NY
%A Kuo SC
%A Wei CC
%A Lai CT
%A Chen HS
%A Wang YH
%A Wei JC
%A Tsai YY
%J JAMA Netw Open
%V 7
%N 7
%D 2024 Jul 1
%M 38949811
%F 13.353
%R 10.1001/jamanetworkopen.2024.19366
%X <B>UNASSIGNED: </B>The long-term estimated risk of development of cataracts among pediatric patients with uveitis is not clear.<BR><B>UNASSIGNED: </B>To describe factors associated with the development of cataracts among pediatric patients with uveitis.<BR><B>UNASSIGNED: </B>This cohort study used the international TriNetX database to enroll pediatric patients with and without uveitis from January 1, 2002, to December 31, 2022. The nonuveitis cohort consisted of randomly selected control patients matched by age, sex, race and ethnicity, and specific comorbidities.<BR><B>UNASSIGNED: </B>Diagnosis of uveitis, identified using diagnostic codes.<BR><B>UNASSIGNED: </B>The primary outcome was the risk of developing cataracts among the uveitis group compared with the nonuveitis comparison group, with hazard ratios (HRs) and 95% CIs reported.<BR><B>UNASSIGNED: </B>A total of 22 687 pediatric patients with uveitis (mean [SD] age, 10.3 [5.6] years; 54.2% male) and 22 687 comparators without uveitis (mean [SD] age, 10.3 [5.6] years; 54.5% male) were enrolled in the study. The risk of cataracts was increased among pediatric patients with uveitis up to a follow-up duration of 20 years (HR, 17.17; 95%CI, 12.90-22.80) from the index date. Subgroup analyses revealed an elevated cataract risk across age groups: 0 to 6 years (HR, 19.09; 95% CI, 10.10-36.00), 7 to 12 years (HR, 27.16; 95% CI, 15.59-47.20), and 13 to 18 years (HR, 13.39; 95% CI, 8.84-20.30); both female sex (HR, 13.76; 95% CI, 9.60-19.71) and male sex (HR, 11.97; 95% CI, 8.47-16.91); and Asian (HR, 13.80; 95% CI, 3.28-58.07), Black or African American (HR, 10.41; 95% CI, 5.60-19.36), and White (HR, 15.82; 95% CI, 11.05-22.60) race. Furthermore, increased cataract risks were also observed among those with and without a history of immunosuppressive agents (with: HR, 26.52 [95% CI, 16.75-41.90]; without: HR, 17.69 [95% CI: 11.39-27.40]), a history of steroid eye drop use (with: HR, 29.51 [95% CI, 14.56-59.70]; without: HR, 16.49 [95% CI, 11.92-22.70]), and a history of intraocular procedures (with: HR, 11.07 [95%CI, 4.42-27.71]; without: HR, 14.49 [95% CI, 10.11-20.70]).<BR><B>UNASSIGNED: </B>In this cohort study of pediatric patients with uveitis, an elevated risk of cataracts following a uveitis diagnosis was found compared with pediatric patients without uveitis. The findings suggest that pediatric patients with uveitis should be monitored for cataract development.